Description

This EASL Studio episode explores state-of-the-art practices in diagnosing steatotic liver disease and stratifying patients effectively for targeted treatment in 2025. Focusing on integrating cardiometabolic risk profiling and dynamic alcohol consumption assessment, the discussion will discuss contemporary methods, frequency, and practical implementation in clinical settings to enhance precision medicine approaches.

Moderator: Aleksander Krag 

Faculty: Meena Bansal, Mattias Ekstedt, Arun Sanyal 

ℹ️ Please click here to access the podcast version of this EASL Studio episode.